{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T12:56:39Z","timestamp":1765544199815,"version":"3.44.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":6768,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1038\/labinvest.3700113","type":"journal-article","created":{"date-parts":[[2004,5,3]],"date-time":"2004-05-03T05:42:40Z","timestamp":1083562960000},"page":"908-914","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Prospective evaluation of blood concentration of mitochondrial DNA as a marker of toxicity in 157 consecutively recruited untreated or HAART-treated HIV-positive patients"],"prefix":"10.1016","volume":"84","author":[{"given":"Franck","family":"Chiappini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elina","family":"Teicher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rapha\u00ebl","family":"Saffroy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Falissard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Barrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Chevalier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Debuire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Vittecoq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoinette","family":"Lemoine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/labinvest.3700113_bib1","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(98)03391-1","article-title":"Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance","volume":"351","author":"Carr","year":"1998","journal-title":"Lancet"},{"key":"10.1038\/labinvest.3700113_bib2","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1056\/NEJM199804303381808","article-title":"HIV-protease inhibitors","volume":"338","author":"Flexner","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1038\/labinvest.3700113_bib3","doi-asserted-by":"crossref","first-page":"37514","DOI":"10.1074\/jbc.M104557200","article-title":"HIV protease inhibitor induces fatty acid and sterol biosynthesis in liver and adipose tissues due to the accumulation of activated sterol regulatory element-binding proteins in the nucleus","volume":"276","author":"Riddle","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.3700113_bib4","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0140-6736(00)04921-7","article-title":"Mitochondrial toxic effects and ribavirin","volume":"357","author":"Salmon-Ceron","year":"2001","journal-title":"Lancet"},{"key":"10.1038\/labinvest.3700113_bib5","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0140-6736(99)06102-4","article-title":"Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy","volume":"354","author":"Brinkman","year":"1999","journal-title":"Lancet"},{"key":"10.1038\/labinvest.3700113_bib6","doi-asserted-by":"crossref","first-page":"F25","DOI":"10.1097\/00002030-200002180-00001","article-title":"A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome","volume":"14","author":"Carr","year":"2000","journal-title":"AIDS"},{"key":"10.1038\/labinvest.3700113_bib7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0022-510X(99)00126-4","article-title":"Zidovudine-induced experimental myopathy: dual mechanism of mitochondrial damage","volume":"166","author":"Masini","year":"1999","journal-title":"J Neurol Sci"},{"key":"10.1038\/labinvest.3700113_bib8","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0140-6736(99)00301-3","article-title":"HIV nucleoside analogues: new adverse effects on mitochondria?","volume":"354","author":"Morris","year":"1999","journal-title":"Lancet"},{"key":"10.1038\/labinvest.3700113_bib9","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/clinids\/21.4.973","article-title":"Massive hepatic steatosis and lactic acidosis in a patient with AIDS who was receiving zidovudine","volume":"4","author":"Olano","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1038\/labinvest.3700113_bib10","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0168-8278(00)80088-4","article-title":"Fatal lactic acidosis and liver steatosis associated with didanosine and stavudine treatment: a respiratory chain dysfunction?","volume":"32","author":"Brivet","year":"2000","journal-title":"J Hepatol"},{"key":"10.1038\/labinvest.3700113_bib11","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1258\/0956462001916498","article-title":"Clinical features and risk factors of lactic acidosis following long-term antiretroviral therapy: 4 fatal cases","volume":"11","author":"ter Hofstede","year":"2000","journal-title":"Int J STD AIDS"},{"key":"10.1038\/labinvest.3700113_bib12","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0168-8278(99)80020-8","article-title":"Zidovudine-induced mitochondrial disorder with massive liver steatosis, myopathy, lactic acidosis, and mitochondrial DNA depletion","volume":"30","author":"Chariot","year":"1999","journal-title":"J Hepatol"},{"key":"10.1038\/labinvest.3700113_bib13","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1086\/313912","article-title":"Hyperlactatemia and hepatic abnormalities in 10 human immunodeficiency virus-infected patients receiving nucleoside analogue combination regimens","volume":"31","author":"Lonergan","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1038\/labinvest.3700113_bib14","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1086\/324353","article-title":"Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study","volume":"33","author":"Boubaker","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1038\/labinvest.3700113_bib15","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/00002030-200104130-00016","article-title":"Management of hyperlactatemia: no need for routine lactate measurements","volume":"15","author":"Brinkman","year":"2001","journal-title":"AIDS"},{"key":"10.1038\/labinvest.3700113_bib16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev.med.50.1.111","article-title":"Mitochondrial disorders: clinical and genetic features","volume":"50","author":"Simon","year":"1999","journal-title":"Annu Rev Med"},{"key":"10.1038\/labinvest.3700113_bib17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1086\/313921","article-title":"Hyperlactatemia and hepatic steatosis as features of mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors","volume":"31","author":"Brinkman","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1038\/labinvest.3700113_bib18","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa012035","article-title":"Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients","volume":"346","author":"Cote","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1038\/labinvest.3700113_bib19","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1097\/00126334-200309011-00013","article-title":"Mitochondrial toxicity in the era of HAART: evaluating venous lactae and peripheral blood mitochondrial DNA in HIV-infecting patients taking antiretroviral therapy","volume":"34","author":"Montaner","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1038\/labinvest.3700113_bib20","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1097\/00002030-200211080-00009","article-title":"Increased long-term mitochondrial toxicity in combinations of nucleoside analogue reverse-transcriptase inhibitors","volume":"16","author":"Walker","year":"2002","journal-title":"AIDS"},{"key":"10.1038\/labinvest.3700113_bib21","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1097\/00002030-200212060-00018","article-title":"Lymphocyte mitochondrial biomarkers in asymptomatic HIV-1-infected individuals treated with nucleoside reverse transcriptase inhibitors","volume":"16","author":"Henry","year":"2002","journal-title":"AIDS"},{"key":"10.1038\/labinvest.3700113_bib22","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00002030-200203080-00001","article-title":"Analysis of mitochondrial DNA genome in the peripheral blood leukocytes of HIV-infected patients with or without lipoatrophy","volume":"16","author":"McComsey","year":"2002","journal-title":"AIDS"},{"key":"10.1038\/labinvest.3700113_bib23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1386-6532(01)00195-0","article-title":"Quantification of mitochondrial DNA in peripheral blood mononuclear cells and subcutaneous fat using real-time polymerase chain reaction","volume":"22","author":"Gahan","year":"2001","journal-title":"J Clin Virol"},{"key":"10.1038\/labinvest.3700113_bib24","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/10618600.1996.10474713","article-title":"R: a language of data analysis and graphics","volume":"5","author":"Ihaka","year":"1996","journal-title":"J Comput Graph Stat"},{"key":"10.1038\/labinvest.3700113_bib25","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00126334-200308010-00006","article-title":"Quantitation of blood lymphocyte mitochondrial dna for the monitoring of antiretroviral drug-induced mitochondrial DNA depletion","volume":"33","author":"Petit","year":"2003","journal-title":"J Acquir Immune Deficiency Syndrome"},{"key":"10.1038\/labinvest.3700113_bib26","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1097\/00002030-199910010-00004","article-title":"Both necrosis and apoptosis contribute to HIV-1-induced killing of CD4 cells","volume":"13","author":"Plymale","year":"1999","journal-title":"AIDS"},{"key":"10.1038\/labinvest.3700113_bib27","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1749-6632.2000.tb05609.x","article-title":"Mitochondrial control of cell death induced by HIV-1-encoded proteins","volume":"926","author":"Ferri","year":"2000","journal-title":"Ann NY Acad Sci"},{"key":"10.1038\/labinvest.3700113_bib28","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1046\/j.1365-2249.2000.01375.x","article-title":"Apoptosis and apoptosis-associated perturbations of peripheral blood lymphocytes during HIV infection:comparison between AIDS patients and asymptomatic long-term non-progressors","volume":"122","author":"Moretti","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1038\/labinvest.3700113_bib29","doi-asserted-by":"crossref","first-page":"7637","DOI":"10.1128\/JVI.75.16.7637-7650.2001","article-title":"Binding of human immunodeficiency virus type 1 gp120 to CXCR4 induces mitochondrial transmembrane depolarization and cytochrome c-mediated apoptosis independently of Fas signaling","volume":"7","author":"Roggero","year":"2001","journal-title":"J Virol"},{"key":"10.1038\/labinvest.3700113_bib30","first-page":"S197","article-title":"HIV-associated lipodystrophy syndrome","volume":"14","author":"Mauss","year":"2000","journal-title":"AIDS"},{"key":"10.1038\/labinvest.3700113_bib31","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(98)08468-2","article-title":"Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study","volume":"353","author":"Carr","year":"1999","journal-title":"Lancet"},{"key":"10.1038\/labinvest.3700113_bib32","first-page":"42","article-title":"Protease inhibitors and nucleoside analogue reverse transcriptase inhibitors interact to cause subcutaneous fat wasting in patients with HIV infection. 1st International Workshop on Adverse Drug Reactions and Lipodystrophy, San Diego [abstract 026]","volume":"4","author":"Mallal","year":"1999","journal-title":"Antiviral Ther"},{"key":"10.1038\/labinvest.3700113_bib33","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/00002030-200007070-00002","article-title":"Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection","volume":"14","author":"Mallal","year":"2000","journal-title":"AIDS"},{"key":"10.1038\/labinvest.3700113_bib34","first-page":"47","article-title":"Lipodystrophic syndromes in a cohort of HIV-1-infected patients receiving HAART with a proteas inhibitor. 1st International Workshop on Adverse Drug Reactions and Lipodystrophy, San Diego, 1999 [abstract 026]","volume":"4","author":"Viard","year":"1999","journal-title":"Antiviral Ther"},{"key":"10.1038\/labinvest.3700113_bib35","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/00126334-200301010-00015","article-title":"Agreement analysis of variables involved in lipodystrophy syndrome definition in HIV-infected patients","volume":"32","author":"Belloso","year":"2003","journal-title":"J Acquir Immune Deficiency Syndrome"},{"key":"10.1038\/labinvest.3700113_bib36","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1086\/339954","article-title":"Metabolic acidosis in HIV-infected patients","volume":"34","author":"Bonnet","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1038\/labinvest.3700113_bib37","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1086\/323980","article-title":"Symptomatic elevations of lactic acid and their response to treatment manipulation in human immunodeficiency virus-infected persons: a case series","volume":"33","author":"Delgado","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1038\/labinvest.3700113_bib38","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1097\/00002030-200012010-00012","article-title":"Symptomatic hyperlactataemia: an emerging complication of antiretroviral therapy","volume":"14","author":"Gerard","year":"2000","journal-title":"AIDS"},{"key":"10.1038\/labinvest.3700113_bib39","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/00002030-200104130-00007","article-title":"Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy","volume":"15","author":"John","year":"2001","journal-title":"AIDS"},{"key":"10.1038\/labinvest.3700113_bib40","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1128\/AAC.46.5.1610-1613.2002","article-title":"Tenofovir diphosphate is a poor substrate and a weak inhibitor of rat DNA polymerases alpha, delta, and epsilon","volume":"46","author":"Birkus","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1038\/labinvest.3700113_bib41","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0149-2918(00)90004-3","article-title":"Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity","volume":"22","author":"Kakuda","year":"2000","journal-title":"Clin Ther"},{"key":"10.1038\/labinvest.3700113_bib42","doi-asserted-by":"crossref","first-page":"23616","DOI":"10.1074\/jbc.M101114200","article-title":"Differential incorporation and removal of antiviral deoxynucleotides by human DNA polymerase gamma","volume":"276","author":"Lim","year":"2001","journal-title":"J Biol Chem"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/3700113.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/3700113","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002368372202253X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002368372202253X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/3700113.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:47:03Z","timestamp":1758397623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002368372202253X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S002368372202253X"],"URL":"https:\/\/doi.org\/10.1038\/labinvest.3700113","relation":{},"ISSN":["0023-6837"],"issn-type":[{"type":"print","value":"0023-6837"}],"subject":[],"published":{"date-parts":[[2004,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective evaluation of blood concentration of mitochondrial DNA as a marker of toxicity in 157 consecutively recruited untreated or HAART-treated HIV-positive patients","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/labinvest.3700113","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2004 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}